Greatbatch, Inc. (NYSE:GB) today announced that it will host a meeting for institutional investors and research analysts on Monday, March 18, 2013 from 12:00 p.m. to 5:00 p.m. ET at the Millennium Broadway Hotel, New York, New York.
At this half day session, Greatbatch President and CEO, Thomas J. Hook and Senior Vice President and CFO, Michael Dinkins will discuss the company’s core business and how it is driving organic growth and financial performance. They will also provide a comprehensive review of Algostim, an innovative, internally developed spinal cord stimulation system which is nearing completion. In addition, 2013 financial guidance will be reviewed along with an outlook of long term growth prospects.
About Greatbatch, Inc.
Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neuromodulation, vascular and orthopaedic markets. Electrochem designs and manufactures batteries for high-end niche applications in the portable medical, energy, military, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at www.greatbatch.com.Business Wire
Last updated on: 15/02/2013
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.